Skip to main content
. 2021 Sep 2;20(10):4758–4770. doi: 10.1021/acs.jproteome.1c00406

Table 1. Comparison between Demographic and Clinical Characteristics of Patients Enrolled in the Original MAGIC Study (n = 327)28,29 and Those Analyzed in the Present Study where Metabolomics Analysis Was Performed (n = 248).

demographic and clinical characteristics at baseline (mean ± standard deviation SD) this study (n = 248) original study group (n = 327) P-value
age (years) 68.8 ± 11.9 68.9 ± 12.0 0.88
sex (male), n 137 190 0.68
onset to treatment time (minutes) 163.4 ± 83.7 163.5 ± 75.7 0.86
baseline National Institute of Health stroke scale 11.9 ± 6.1 11.9 ± 6.0 0.94
baseline systolic blood pressure (mmHg) 147.5 ± 21.3 148.2 ± 21.7 0.69
baseline diastolic blood pressure (mmHg) 79.7 ± 12.7 80.1 ± 12.7 0.71
blood glucose (mg/dL) 130.2 ± 49.5 130.2 ± 47.9 0.99
risk factors
hypertension (m) 143 197 0.77
diabetes (m) 36 50 0.89
hyperlipidemia (m) 56 81 0.68
current smoking (m) 35 51 0.70
atrial fibrillation (m) 56 73 0.83
congestive heart failure (m) 26 35 0.98